Upcoming webinar

Advancing the Pharmaceutical Development of Orphan Drugs for Rare Diseases

Downloading our Whitepaper

You are about to download this document, please enter your contact details below to start downloading.


Strategies for Accelerating the Development of Modified Release Oral Forms

MR drug delivery can also have commercial benefits and is prevalent as part of product life-cycle management (LCM). Modest reformulation of an already approved drug from an IR to MR format allows both line and patent extension opportunities and continued market exclusivity.

Would you like to receive further scientific content including case studies, whitepapers and seminar and webinar invitations?
You can find out how we handle your personal information in our privacy policy here.

Ask us a question

We use cookies to help us to improve our site and enables us to the best possible service and customer experience. By clicking accept you are agreeing to let us share your data with select third parties for analytics and marketing purposes.